Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
197 Leser
Artikel bewerten:
(1)

YourBio Health and RecoveryTrek Partner to Offer Painless and Convenient Alcohol Biomarker Testing

MEDFORD, Mass., July 16, 2024 /PRNewswire/ -- YourBio Health and RecoveryTrek today announced a partnership to provide phosphatidylethanol (PEth) alcohol biomarker testing to substance use disorder patients and participants in professional monitoring and treatment programs. The partnership leverages the PROOF virtual remote collection and testing solution in conjunction with the YourBio Health TAP® Micro Select device. Beginning this month, professional monitoring participants will receive a PROOF kit which provides anywhere, anytime, remote workplace or at-home drug, alcohol, and healthcare diagnostic testing powered by YourBio Health's innovative blood sampling technology.

YourBio Health Logo

The TAP® Micro Select device offers a virtually painless blood sampling experience for providers and patients. Compared to traditional venipuncture and fingerstick lancets, TAP® devices provide a more patient centric option for blood sampling that patients find less painful and easy to use, leading to higher compliance rates in testing.

"As part of our mission to transform recovery, monitoring and health & wellness and enable participants, as well as consumers to take control of their health and journey through recovery, we are thrilled to partner with YourBio Health to make it easier, more convenient and less painful for people to access critical testing," said Kirk Cizerle, CEO of RecoveryTrek. "By offering TAP® devices for clinical-grade blood sampling as part of our testing kits - available through our website - we are providing an improved experience and addressing participant and consumer needs."

PROOF offers numerous virtual, remote at-home testing kits for a variety of drug and alcohol testing methods. The PROOF app directs providers and patients with step-by-step instruction to ensure proper collection, with guided voice instruction and visuals to walk patients through the process.

"As part of our commitment to advancing health innovation in blood sampling, we are excited to collaborate with the RecoveryTrek team to enhance accessibility and comfort in alcohol biomarker testing," said Paul Owen, CEO and President of YourBio Health. "Integrating the TAP® Micro Select device into the PROOF platform sets up patients and providers for successful testing with this user-friendly, patient-centered solution from RecoveryTrek."

To learn more, visit collectwithproof.com and yourbiohealth.com.

About RecoveryTrek

RecoveryTrek, LLC is headquartered in Norfolk, Virginia. The company provides state-of-the-art; customized software solutions for organizations and individuals focused on behavioral health and reduction of substance abuse. Since 2011, RecoveryTrek has partnered with a wide variety of professional monitoring programs, treatment centers, non-profit organizations and individuals all with a desire to incorporate the most advanced evidenced-based tools including software, mobile, and laboratory solutions into their treatment protocols.

About YourBio Health

YourBio Health is a Flagship Pioneering portfolio company that invented 'Touch-Activated Phlebotomy' (TAP) for virtually painless whole capillary blood collection using devices incorporating patented technology. This technology eliminates barriers to blood collection by allowing a capillary blood sample to be collected from any physical location without the pain of a fingerstick or the need for traditional phlebotomy.

Logo - https://mma.prnewswire.com/media/2461303/YBH_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/yourbio-health-and-recoverytrek-partner-to-offer-painless-and-convenient-alcohol-biomarker-testing-302196960.html

© 2024 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.